GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kanabo Group PLC (LSE:KNB) » Definitions » EV-to-FCF

Kanabo Group (LSE:KNB) EV-to-FCF : -1.97 (As of Dec. 11, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kanabo Group EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Kanabo Group's Enterprise Value is £4.67 Mil. Kanabo Group's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was £-2.37 Mil. Therefore, Kanabo Group's EV-to-FCF for today is -1.97.

The historical rank and industry rank for Kanabo Group's EV-to-FCF or its related term are showing as below:

LSE:KNB' s EV-to-FCF Range Over the Past 10 Years
Min: -3.84   Med: -1.82   Max: -0.48
Current: -1.97

During the past 7 years, the highest EV-to-FCF of Kanabo Group was -0.48. The lowest was -3.84. And the median was -1.82.

LSE:KNB's EV-to-FCF is ranked worse than
100% of 404 companies
in the Healthcare Providers & Services industry
Industry Median: 18.205 vs LSE:KNB: -1.97

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-11), Kanabo Group's stock price is £0.0095. Kanabo Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.014. Therefore, Kanabo Group's PE Ratio (TTM) for today is At Loss.


Kanabo Group EV-to-FCF Historical Data

The historical data trend for Kanabo Group's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kanabo Group EV-to-FCF Chart

Kanabo Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial -2.24 -2.64 -22.39 -1.28 -5.34

Kanabo Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.28 - -5.34 -

Competitive Comparison of Kanabo Group's EV-to-FCF

For the Medical Care Facilities subindustry, Kanabo Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kanabo Group's EV-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kanabo Group's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Kanabo Group's EV-to-FCF falls into.



Kanabo Group EV-to-FCF Calculation

Kanabo Group's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=4.670/-2.369
=-1.97

Kanabo Group's current Enterprise Value is £4.67 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kanabo Group's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was £-2.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kanabo Group  (LSE:KNB) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Kanabo Group's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0095/-0.014
=At Loss

Kanabo Group's share price for today is £0.0095.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kanabo Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.014.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Kanabo Group EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Kanabo Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Kanabo Group Business Description

Traded in Other Exchanges
Address
137-139 Brent Street, Churchill House, London, GBR, NW4 4DJ
Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment, which derives key revenue, includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom and Israel.

Kanabo Group Headlines

No Headlines